Skip to main content

Advertisement

SpringerLink
Log in

Antidepressant use and breast cancer risk

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Background

Antidepressants are among the most commonly prescribed drugs in the United States. Laboratory studies suggest that because certain antidepressants increase prolactin levels that they may also increase breast cancer risk. However, human studies evaluating use of antidepressants in relation to breast cancer risk have yielded inconsistent results.

Methods

A population-based case-control study consisting of 975 breast cancer cases 65–79 years of age diagnosed from 1997–1999 and 1007 age and residence-matched controls was conducted in western Washington State. Detailed information on antidepressant use was obtained through structured in-person interviews. Logistic regression was performed to analyze the relationship between antidepressant use and breast cancer risk.

Results

Overall, there was no association between ever use of antidepressants and breast cancer risk (odds ratio [OR] = 1.2, 95% confidence interval [95% CI]: 0.9–1.6). When evaluated separately, tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), and triazolopyridines were each not associated with breast cancer risk. However, risk varied by hormone receptor status. Compared to never users, ever users of SSRIs had elevated risks of progesterone receptor (PR) negative and estrogen receptor (ER) positive/PR-negative breast cancers (OR = 1.8, 95% CI: 1.1–3.6 and OR = 2.0, 95% CI: 1.1–3.8, respectively), but not of tumors with other hormone receptor profiles.

Conclusions

Based on these results and those of previous studies, there is limited evidence that any type of antidepressant use is associated with breast cancer risk overall. SSRIs may elevate risks of PR- and ER+/PR- tumors, though further studies are needed to confirm these associations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Top 200 Drugs of 2002 [http://www.pharmacytimes.com/article.cfm?ID=338]

  2. Stafford RS, MacDonald EA, Finkelstein SN, 2001. National patterns of medication treatment for depression, 1987 to 2001 Prim Care Companion J Clin Psychiat 3:232–235

    Google Scholar 

  3. Ohayon MM, Lader MH, 2002. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom J Clin Psychiat 63: 817–825

    Google Scholar 

  4. Brandes LJ, Arron RJ, Bogdanovic RP, Tong J, Zaborniak CL, Hogg GR, Warrington RC, Fang W, LaBella FS, 1992. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses Cancer Res 52: 3796–3800

    PubMed  CAS  Google Scholar 

  5. Hilakivi-Clarke L, Wright A, Lippman ME, 1993. DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment Physiol Behav 54: 229–236

    Article  PubMed  CAS  Google Scholar 

  6. Leatherman ME, Ekstrom RD, Corrigan M, Carson SW, Mason G, Golden RN, 1993. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment Psychopharmacol Bull 29: 149–154

    PubMed  CAS  Google Scholar 

  7. Cowen PJ, Sargent PA, 1997. Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission J Psychopharmacol 11: 345–348

    Article  PubMed  CAS  Google Scholar 

  8. Urban RJ, Veldhuis JD, 1991. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women Am J Obstet Gynecol 164: 147–152

    PubMed  CAS  Google Scholar 

  9. Kiss R, de Launoit Y, L’Hermite-Baleriaux M, L’Hermite M, Paridaens RJ, Danguy AJ, Pasteels JL, 1987. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm J Natl Cancer Inst 78: 993–998

    PubMed  CAS  Google Scholar 

  10. Welsch CW, Nagasawa H, 1977. Prolactin and murine mammary tumorigenesis: a review Cancer Res 37: 951–963

    PubMed  CAS  Google Scholar 

  11. Wang DY, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Fentiman IS, Hayward JL, Millis RR, 1992. Relationship of blood prolactin levels and the risk of subsequent breast cancer Int J Epidemiol 21: 214–221

    Article  PubMed  CAS  Google Scholar 

  12. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, 2000. A prospective study of estradiol and breast cancer in Japanese women Cancer Epidemiol Biomarkers Prev 9: 575–579

    PubMed  CAS  Google Scholar 

  13. Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B, Speizer FE, 1999. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 91: 629–634

    Article  PubMed  CAS  Google Scholar 

  14. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE, 2004. Plasma prolactin concentrations and risk of postmenopausal breast cancer Cancer Res 64: 6814–6819

    Article  PubMed  CAS  Google Scholar 

  15. Hermann B, Vollmer I, Holsboer F, Rupprecht R, 2001. Antidepressants do not modulate estrogen receptor alpha-mediated gene expression J Neural Transm 108: 1197–1202

    Article  PubMed  CAS  Google Scholar 

  16. Kuiper GG, Shughrue PJ, Merchenthaler I, Gustafsson JA, 1998. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems Front Neuroendocrinol 19: 253–286

    Article  PubMed  CAS  Google Scholar 

  17. Laudenslager ML, Clarke AS, 2000. Antidepressant treatment during social challenge prior to 1 year of age affects immune and endocrine responses in adult macaques Psychiat Res 95: 25–34

    Article  CAS  Google Scholar 

  18. Eisen JN, Irwin J, Quay J, Livnat S, 1989. The effect of antidepressants on immune function in mice Biol Psychiat 26: 805–817

    Article  PubMed  CAS  Google Scholar 

  19. Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J, 2001. Antidepressant use and the risk of breast cancer: a non-association J Clin Epidemiol 54: 728–734

    Article  PubMed  CAS  Google Scholar 

  20. Cotterchio M, Kreiger N, Darlington G, Steingart A, 2000. Antidepressant medication use and breast cancer risk Am J Epidemiol 151: 951–957

    PubMed  CAS  Google Scholar 

  21. Moorman PG, Grubber JM, Millikan RC, Newman B, 2003. Antidepressant Medications and Their Association with Invasive Breast Cancer and Carcinoma in situ of the Breast Epidemiology 14: 307–314

    Article  PubMed  Google Scholar 

  22. Gonzalez-Perez A, Garcia Rodriguez LA, 2005. Breast cancer risk among users of antidepressant medications Epidemiology 16: 101–105

    Article  PubMed  Google Scholar 

  23. Kato I, Zeleniuch-Jacquotte A, Toniolo PG, Akhmedkhanov A, Koenig K, Shore RE, 2000. Psychotropic medication use and risk of hormone-related cancers: the New York University Women’s Health Study J Public Health Med 22: 155–160

    Article  PubMed  CAS  Google Scholar 

  24. Steingart A, Cotterchio M, Kreiger N, Sloan M, 2003. Antidepressant medication use and breast cancer risk: a case-control study Int J Epidemiol 32: 961–966

    Article  PubMed  Google Scholar 

  25. Kelly JP, Rosenberg L, Palmer JR, Rao RS, Strom BL, Stolley PD, Zauber AG, Shapiro S, 1999. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines Am J Epidemiol 150: 861–868

    PubMed  CAS  Google Scholar 

  26. Lawlor DA, Juni P, Ebrahim S, Egger M, 2003. Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer J Clin Epidemiol 56: 155–163

    Article  PubMed  Google Scholar 

  27. Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR, 2004. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women Am J Epidemiol 159: 308–317

    Article  PubMed  Google Scholar 

  28. Armstrong BK, White E, Saracci R: Reducing measurement error, its effects. In: Principles of Exposure Measurement in Epidemiology. Oxford University Press, Oxford, 1992, pp.115–136

  29. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI, Sutherland RL, 1997. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer J Clin Endocrinol Metab 82: 3692–3699

    Article  PubMed  CAS  Google Scholar 

  30. Gutzman JH, Miller KK, Schuler LA, 2004. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells J Steroid Biochem Mol Biol 88: 69–77

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, USA

    Chloe Chien, Christopher I. Li, Kathleen E. Malone & Janet R. Daling

  2. Department of Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle, USA

    Susan R. Heckbert

  3. Group Health Cooperative, Center for Health Studies, Seattle, WA, USA

    Denise M. Boudreau

Authors
  1. Chloe Chien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher I. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan R. Heckbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kathleen E. Malone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Denise M. Boudreau
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janet R. Daling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chloe Chien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chien, C., Li, C.I., Heckbert, S.R. et al. Antidepressant use and breast cancer risk. Breast Cancer Res Treat 95, 131–140 (2006). https://doi.org/10.1007/s10549-005-9056-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9056-0

Keywords

Search

Navigation